Association between a functional single nucleotide polymorphism in the MDM2 gene and sporadic endometrial cancer risk. (Q51775699)

12 April 2018

title

Association between a functional single nucleotide polymorphism in the MDM2 gene and sporadic endometrial cancer risk. (English)

1 reference

12 April 2018

single-nucleotide polymorphism

main subject

1 reference

1 reference

Christine S Walsh

1

1 reference

12 April 2018

Carl W Miller

series ordinal

2

1 reference

12 April 2018

Beth Y Karlan

series ordinal

3

1 reference

12 April 2018

H Phillip Koeffler

series ordinal

4

1 reference

12 April 2018

language of work or name

English

0 references

publication date

21 November 2006

1 reference

12 April 2018

published in

Gynecologic Oncology

1 reference

12 April 2018

volume

104

1 reference

12 April 2018

page(s)

660-664

1 reference

12 April 2018

issue

3

1 reference

12 April 2018

Gynecologic cancer as a "sentinel cancer" for women with hereditary nonpolyposis colorectal cancer syndrome.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.10.008

Prevalence of defective DNA mismatch repair and MSH6 mutation in an unselected series of endometrial cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.10.008

Genetic testing in hereditary non-polyposis colorectal cancer families with a MSH2, MLH1, or MSH6 mutation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.10.008

Discovering genotypes underlying human phenotypes: past successes for mendelian disease, future approaches for complex disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.10.008

p53, the cellular gatekeeper for growth and division

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.10.008

Post-translational modifications and activation of p53 by genotoxic stresses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.10.008

The p53 tumor suppressor gene: from molecular biology to clinical investigation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.10.008

Rearrangement of the p53 gene in human osteogenic sarcomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.10.008

p53 mutations in human cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.10.008

P53 and prognosis: new insights and further complexity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.10.008

mdm-2 inhibits the G1 arrest and apoptosis functions of the p53 tumor suppressor protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.10.008

Regulation of p53 stability by Mdm2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.10.008

Mdm2 promotes the rapid degradation of p53

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.10.008

The p53 and Mdm2 families in cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.10.008

Amplification of a gene encoding a p53-associated protein in human sarcomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.10.008

MDM2 and human malignancies: expression, clinical pathology, prognostic markers, and implications for chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.10.008

The MDM2 gene amplification database

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.10.008

A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.10.008

The role of P53 and MDM2 polymorphisms in the risk of esophageal squamous cell carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.10.008

A chromatin-associated and transcriptionally inactive p53-Mdm2 complex occurs in mdm2 SNP309 homozygous cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.10.008

The MDM2 promoter polymorphism SNP309T-->G and the risk of uterine leiomyosarcoma, colorectal cancer, and squamous cell carcinoma of the head and neck

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.10.008

MDM2 SNP309 Accelerates Tumor Formation in a Gender-Specific and Hormone-Dependent Manner

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.10.008

Estrogen receptor-dependent proteasomal degradation of the glucocorticoid receptor is coupled to an increase in mdm2 protein expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.10.008

Estrogen receptor/Sp1 complexes are required for induction of cad gene expression by 17beta-estradiol in breast cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.10.008

Cell- and ligand-specific regulation of promoters containing activator protein-1 and Sp1 sites by estrogen receptors alpha and beta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.10.008

Transcriptional activation of genes by 17 beta-estradiol through estrogen receptor-Sp1 interactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.10.008

Association of a functional polymorphism in the promoter of the MDM2 gene with risk of nonsmall cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.10.008

Direct sequencing of the p53 gene shows absence of mutations in endometrioid endometrial adenocarcinomas expressing p53 protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.10.008

Genetic polymorphisms in cell cycle regulatory genes MDM2 and TP53 are associated with susceptibility to lung cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.10.008

Polymorphisms in the MDM2 promoter and risk of breast cancer: a case-control analysis in a Chinese population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.10.008

No association of the MDM2 SNP309 polymorphism with risk of breast or ovarian cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.10.008

The Sequence of the Human Genome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.10.008

A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.10.008

Distinctive p53 and mdm2 immunohistochemical expression profiles suggest different pathogenetic pathways in poorly differentiated endometrial carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.10.008

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.YGYNO.2006.10.008

1 reference

12 April 2018

PubMed ID

17123590

1 reference

12 April 2018